ENTANasdaq United States
Market cap
$400.409 M
$13.77 +3.22%
Close of 7 Aug 2026
Revenue
$65.3M
#2663 by revenue
Earnings
-$81.9M
Loss-making
Shares outstanding
29,078,380
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Enanta Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.